InsiderTrades.com logo
Tiny Biotech Stock Wins $75 Billion Patent
From Behind the Markets   |   Ad
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Find out more here >>>

TAVI Insider Trading

Insider Ownership Percentage: 63.33%
Insider Buying (Last 12 Months): £31,620
Insider Selling (Last 12 Months): GBX 0

Tavistock Investments Insider Trading History Chart

This chart shows the insider buying and selling history at Tavistock Investments by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Tavistock Investments Share Price & Price History

Current Price: GBX 4.62
Price Change: ▼ Price Decrease of -0.13 (-2.74%)
As of 04/19/2024 02:53 PM ET

This chart shows the closing price history over time for TAVI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Tiny Biotech Stock Wins $75 Billion Patent
From Behind the Markets   |   Ad
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Find out more here >>>

Tavistock Investments Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/5/2024Brian RavenInsiderBuy30,000GBX 5£1,500
1/3/2024Brian RavenInsiderBuy753,000GBX 4£30,120
8/16/2022Brian RavenInsiderBuy50,000GBX 9£4,500
7/26/2022Oliver Charles CookeInsiderBuy100,000GBX 9£9,000
7/4/2022Brian RavenInsiderBuy140,000GBX 9£12,600
6/29/2022Brian RavenInsiderBuy120,000GBX 8£9,600
6/24/2021Brian RavenInsiderBuy437,000GBX 4£17,480
6/15/2021Brian RavenInsiderBuy900,000GBX 6£54,000
See Full Table
Tiny Biotech Stock Wins $75 Billion Patent
From Behind the Markets   |   Ad
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Find out more here >>>

SEC Filings (Institutional Ownership Changes) for Tavistock Investments (LON:TAVI)

0.08% of Tavistock Investments stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Tavistock Investments logo
Tavistock Investments Plc provides investment management and advisory support services to a network of financial advisers in the United Kingdom. The company offers investment planning, financial planning, pension and retirement planning, estate and legacy planning, protection and insurance, will writing, bereavement notification, employee benefits, protects families from financial difficulty, finance for homes and mortgages, financial management, financial planning, and tax saving services. Tavistock Investments Plc was incorporated in 2004 and is based in Ascot, the United Kingdom.
Read More on Tavistock Investments

Today's Range

Now: GBX 4.62
Low: 4.51
High: 4.93

50 Day Range

MA: GBX 4.69
Low: 3.99
High: 5.75

52 Week Range

Now: GBX 4.62
Low: 3.50
High: 9

Volume

320,666 shs

Average Volume

597,571 shs

Market Capitalization

£25.89 million

P/E Ratio

N/A

Dividend Yield

1.65%

Beta

0.09

Who are the company insiders with the largest holdings of Tavistock Investments?

Tavistock Investments' top insider shareholders include:
  1. Brian Raven (Insider)
  2. Oliver Charles Cooke (Insider)
Learn More about top insider investors at Tavistock Investments.
Tiny Biotech Stock Wins $75 Billion Patent
From Behind the Markets   |   Ad
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Find out more here >>>